Status:
UNKNOWN
Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hyperlipidemia
Hyperglycemia
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and h...
Detailed Description
Evaluation of health effects of domestic adlay on lowering cholesterol and blood sugar Hyperlipidemia and diabetes are major risk factors for cardiovascular disease. Clinical experiments have prelimi...
Eligibility Criteria
Inclusion
- Hyperlipidemia: Levels of LDL-choleterol equal or greater than 130 mg/dL, or triglyceride equal or greater than 150 mg/dL
- Hyperglycemia: fasting glucose equal or greater than 100 mg/dL
Exclusion
- Secondary hyperglycemia Secondary hyperlipidemia
Key Trial Info
Start Date :
July 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05990595
Start Date
July 7 2023
End Date
November 30 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10002